Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity of 56°C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
Davide Brusa, Elisa Migliore, Stefano Garetto, et al.
The Prostate (2009) Vol. 69, Iss. 12, pp. 1343-1352
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, et al.
Nature reviews. Immunology (2016) Vol. 17, Iss. 2, pp. 97-111
Closed Access | Times Cited: 2435
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
OncoImmunology (2014) Vol. 3, Iss. 9, pp. e955691-e955691
Open Access | Times Cited: 755
High-mobility group box 1 and cancer
Daolin Tang, Rui Kang, Herbert J. Zeh, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2010) Vol. 1799, Iss. 1-2, pp. 131-140
Open Access | Times Cited: 504
Inducers of immunogenic cancer cell death
Aleksandra M. Dudek, Abhishek D. Garg, Dmitri V. Krysko, et al.
Cytokine & Growth Factor Reviews (2013) Vol. 24, Iss. 4, pp. 319-333
Open Access | Times Cited: 229
Targeting Hsp70: A possible therapy for cancer
Sanjay Kumar, James Stokes, Udai P. Singh, et al.
Cancer Letters (2016) Vol. 374, Iss. 1, pp. 156-166
Open Access | Times Cited: 210
Vaccine-like nanomedicine for cancer immunotherapy
Yunfei Yi, Mian Yu, Wen Li, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 760-778
Closed Access | Times Cited: 87
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
Irena Adkins, Jitka Fučíková, Abhishek D. Garg, et al.
OncoImmunology (2014) Vol. 3, Iss. 12, pp. e968434-e968434
Open Access | Times Cited: 181
Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: Differences between primary and cancer cells
Jaganmohan R. Jangamreddy, Saeid Ghavami, Jerzy Grabarek, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) Vol. 1833, Iss. 9, pp. 2057-2069
Open Access | Times Cited: 142
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1047-1047
Open Access | Times Cited: 128
Immunogenic Cell Death in Hematological Malignancy Therapy
Zhaoyun Liu, Xintong Xu, Kaining Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 29
Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
Yuk-Wah Tsang, Cheng-Chung Huang, Kai-Lin Yang, et al.
BMC Cancer (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 88
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Lien Vandenberk, Jochen Belmans, Matthias Van Woensel, et al.
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 84
Tumor-intrinsic determinants of immunogenic cell death modalities
Samuel T. Workenhe, Jonathan Pol, Guido Kroemer
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 41
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
Sara De Boo, Joanna Kopecka, Davide Brusa, et al.
Molecular Cancer (2009) Vol. 8, Iss. 1
Open Access | Times Cited: 82
PARG dysfunction enhances DNA double strand break formation in S-phase after alkylation DNA damage and augments different cell death pathways
Hidenori Shirai, Anna R. Poetsch, Atsuko Gunji, et al.
Cell Death and Disease (2013) Vol. 4, Iss. 6, pp. e656-e656
Open Access | Times Cited: 64
Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism
Ana Hernández, Nely Rodríguez, Jorge E. González, et al.
The Journal of Immunology (2011) Vol. 186, Iss. 6, pp. 3735-3744
Open Access | Times Cited: 63
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
Davide Brusa, Mariagrazia Simone, Paolo Gontero, et al.
International Journal of Urology (2013) Vol. 20, Iss. 10, pp. 971-978
Closed Access | Times Cited: 57
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells
Irena Adkins, Lenka Sadílková, Nada Hradilova, et al.
OncoImmunology (2017) Vol. 6, Iss. 5, pp. e1311433-e1311433
Open Access | Times Cited: 52
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Arthur Dyer, Ying Di, Hugo Calderón, et al.
Molecular Therapy — Oncolytics (2016) Vol. 4, pp. 18-30
Open Access | Times Cited: 48
β‐Hydroxybutyric acid attenuates heat stress‐induced neuroinflammation via inhibiting TLR4/p38 MAPK and NF‐κB pathways in the hippocampus
Jian Huang, Xuejun Chai, Yongji Wu, et al.
The FASEB Journal (2022) Vol. 36, Iss. 4
Closed Access | Times Cited: 20
Heat shock proteins in prostate cancer: from tumorigenesis to the clinic
Daniel R. Ciocca, Mariel A. Fanelli, F. Darío Cuello-Carrión, et al.
International Journal of Hyperthermia (2010) Vol. 26, Iss. 8, pp. 737-747
Open Access | Times Cited: 42
Activation of inflammasomes by tumor cell death mediated by gold nanoshells
Hai Truong Nguyen, Kenny K. Tran, Bingbing Sun, et al.
Biomaterials (2011) Vol. 33, Iss. 7, pp. 2197-2205
Open Access | Times Cited: 38
Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death
Qiang Wang, Meijia Ren, Fan Feng, et al.
Molecular Carcinogenesis (2018) Vol. 57, Iss. 7, pp. 903-910
Closed Access | Times Cited: 29
Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions
Cristián Falcón-Beas, Andrés Tittarelli, Gabriela Mora-Bau, et al.
Immunobiology (2019) Vol. 224, Iss. 5, pp. 697-705
Closed Access | Times Cited: 26
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Lina Matera
Cancer Treatment Reviews (2009) Vol. 36, Iss. 2, pp. 131-141
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top